Athenahealth Upbeat on Fed Stimulus - Analyst Blog
21 Octobre 2011 - 5:00PM
Zacks
Leading vendor of cloud-based
services for physician practices Athenahealth
(ATHN) reported third-quarter fiscal 2011 adjusted (excluding
one-time items other than stock-based compensation expense)
earnings of 15 cents per share squeaking past the Zacks Consensus
Estimate of 14 cents.
Net income (as reported) for the
quarter increased to $5.3 million (or 15 cents per share) from $3.8
million (or 11 cents per share) a year ago, partly riding on higher
revenues. The stock was virtually stagnant during after-hours
trading.
Revenues
Revenues for the reported quarter
were up sharply 33% year over year to $83.7 million, beating the
Zacks Consensus Estimate of $83 million. The company recorded
collections of $1.9 billion, up 26.7%.
As for the two reporting segments,
sales from Business Services were up 32% to $80.6 million while
Implementation and Other revenue rose 50.7% to $3.1 million.
Revenues were bolstered by
continued adoption of the company’s revenue cycle management
offering athenaCollector and its electronic health record (“EHR”)
service athenaClinicals by physicians. In addition, usage of
athenaCommunicator is gathering momentum.
Utilization of athenaCollector by
medical providers and physicians increased a respective 20.4% and
21% year over year, in the third quarter. Furthermore, the use of
athenaClinicals by medical providers (as well as physicians) more
than doubled year over year. The usage of athenaCommunicator shot
up exponentially to 4,117 medical providers (of whom 2,931 were
physicians).
Margins
Adjusted gross margin rose to 63.8%
in the quarter from 62.8% a year ago while adjusted EBITDA margin
dropped slightly to 22.6% from 23%. Adjusted operating margin
dipped to 16.9% from 18.5% a year ago.
Balance Sheet
Athenahealth exited the quarter
with cash, cash equivalents and short-term investments of $118.5
million, up 21.4% year over year. The company extinguished
outstanding debt obligations since the prior-year period.
Other
The company set up an online
dashboard reporting on client performance related to meaningful use
requirements. During the quarter, Athenahealth accomplished its
takeover of Proxsys and released the athenaCoordinator offering to
enable hospitals (and other recipients of patient referrals) to
improve coordination of care.
Outlook
Athenahealth raised the low end of
its revenue forecast for fiscal 2011 to $320 million to $325
million (earlier $315 million to $325 million). The company also
hiked adjusted gross margin to a band of 63% to 63.5% (earlier
62.5% to 63.5%) and adjusted EBITDA to a range of $64 million to
$68 million (earlier $59 million to $67 million). The guidance for
adjusted earnings was raised to a band of 78 cents to 85 cents a
share from the earlier projection of 70 cents and 83
cents.
Athenahealth’s web-based deployment
provides a low-cost scalable service while its flexible rules
engine leads to higher efficiency in claims settlement. The
Software-as-a-Service (SaaS)-based approach allows for a more
flexible delivery mechanism that is expected to help Athenahealth
win deals. The company has traditionally enjoyed high customer
satisfaction rates, which facilitate a larger number of
referrals.
Athenahealth’s unique business
model makes it a strong provider of revenue cycle management
(“RCM”) services (athenaCollector) to small physician practices.
Its EHR product (athenaClinical) is a key player in ambulatory
settings. We believe that sales of athenaClinical are likely
to remain robust, given the opportunity for physicians to earn
incentive payments under the federal stimulus.
The company should benefit from its
extensive athenaCollector client base, as only a minority of its
subscriber base also utilizes athenaClinical. Cross selling
represents a real growth opportunity in the near term. In this
regard, Athenahealth has made rapid strides in capturing the EHR
business of physician practices. However, this segment is shrinking
as hospitals increasingly absorb physician practices.
Athenahealth has geared itself for
the enterprise segment through its strategic alliance with
Microsoft (MSFT) and the acquisition of Proxsys,
both earlier in 2011. The company has recently signed on, and
executed several enterprise-sized deals, which provide it with a
credible and reference-able client base.
Though the federal stimulus will
gradually wind down, the replacement market is growing. Competition
is fierce and larger competitors may benefit from the incumbency
factor. Industry stalwarts, such as Cerner (CERN),
offer long-standing seamless products integrating inpatient and
ambulatory-care systems. Quality Systems (QSII)
and Allscripts Healthcare Solutions (MDRX) are two
other well-known competitors in a crowded field, which also
includes low-end players such as Emdeon (EM).
ATHENAHEALTH IN (ATHN): Free Stock Analysis Report
CERNER CORP (CERN): Free Stock Analysis Report
EMDEON INC-A (EM): Free Stock Analysis Report
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis Report
MICROSOFT CORP (MSFT): Free Stock Analysis Report
QUALITY SYS (QSII): Free Stock Analysis Report
Zacks Investment Research
Emdeon Inc. Class A Common Stock (NYSE:EM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Emdeon Inc. Class A Common Stock (NYSE:EM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024